Skip to main content
Top
Published in: Acta Diabetologica 5/2021

01-05-2021 | Insulins | Short Communication

Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy

Authors: Marco Marigliano, Claudio Maffeis

Published in: Acta Diabetologica | Issue 5/2021

Login to get access

Excerpt

The spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has reached pandemic dimensions worldwide [1]. To prevent the outbreak of the coronavirus disease (COVID-19), the lockdown was imposed in Italy on March 9, 2020, changing the daily routine of children and adolescents with type 1 diabetes (T1D). …
Literature
1.
go back to reference Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733CrossRef Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733CrossRef
Metadata
Title
Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy
Authors
Marco Marigliano
Claudio Maffeis
Publication date
01-05-2021
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2021
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-020-01667-6

Other articles of this Issue 5/2021

Acta Diabetologica 5/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.